{"id":130013,"date":"2026-09-23T13:29:49","date_gmt":"2026-09-23T13:29:49","guid":{"rendered":"https:\/\/www.europesays.com\/britain\/130013\/"},"modified":"2026-09-23T13:29:49","modified_gmt":"2026-09-23T13:29:49","slug":"breast-cancer-drug-zoladex-withdrawal-delayed-by-astrazeneca-amid-pbs-talks","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/britain\/130013\/","title":{"rendered":"Breast cancer drug Zoladex withdrawal delayed by AstraZeneca amid PBS talks"},"content":{"rendered":"<p>AstraZeneca will delay the withdrawal of breast cancer drug Zoladex from the Australian market while it attempts to renegotiate a relisting on the Pharmaceutical Benefits Scheme following fierce patient backlash.<\/p>\n<p>Under the new plan, Zoladex will remain on shelves until May 2027 but PBS prescriptions for the Zoladex 3.6mg monthly implant written by April 30 can still be filled until May 1, 2028.<\/p>\n<p>Zoladex is a drug used by women with endometriosis or hormone receptor-positive metastatic breast cancer. It works by suppressing their sex hormones, which can drive the disease. <\/p>\n<p>When AstraZeneca announced its intention to withdraw its 3.6mg dose from the Australian market for financial reasons, affected patients considered the move as a very real threat to their lives. Some were left so distressed that it was <a class=\"body-link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/when-big-pharma-clashes-with-public-policy-people-such-as-aimee-pay-the-price\/news-story\/cf937f473be3e26446690fa9a234c5b3\" target=\"_blank\" data-tgev=\"event119\" data-tgev-container=\"bodylink\" data-tgev-order=\"cf937f473be3e26446690fa9a234c5b3\" data-tgev-label=\"health\" data-tgev-metric=\"ev\" rel=\"nofollow noopener\">a major contributor to their decision to have their ovaries removed<\/a>.<\/p>\n<p>The withdrawal was due to happen in November. Not only would the drug be stripped from the PBS, it would be removed from sales entirely.<\/p>\n<p>At the time, the government expressed its disappointment in the decision and said it had made \u201cextensive and sustained efforts to retain the PBS listing\u201d to no avail. Patient groups admonished both sides.<\/p>\n<p>The dispute came amid growing concern that the <a class=\"body-link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/australian-patients-risk-losing-lifesaving-medicines-amid-pharmaceutical-subsidy-crisis\/news-story\/9fb9250d21bdf486789e6eb8a9b23681\" target=\"_blank\" data-tgev=\"event119\" data-tgev-container=\"bodylink\" data-tgev-order=\"9fb9250d21bdf486789e6eb8a9b23681\" data-tgev-label=\"health\" data-tgev-metric=\"ev\" rel=\"nofollow noopener\">PBS is not fit for purpose and needs considerable amendments<\/a> or drug makers will overlook Australia as a favourable market. The drug\u2019s supply has not been affected in similar international markets. <\/p>\n<p>As anger grew, AstraZeneca announced a community access scheme would be rolled out to give patients with no alternative option ongoing access to the drug for free. However, patients and advocates said the pledge provided no guarantee of supply and could be reneged as easily as it was made.<\/p>\n<p>The Australian can now reveal AstraZeneca and the government have been locked in closed-door negotiations to try to get Zoladex relisted on the PBS at a new price. However, the drug maker\u2019s first application, made just weeks ago, was rejected. <\/p>\n<p>\u201cThe Pharmaceutical Benefits Advisory Committee was unable to grant a price adjustment that would have allowed the continued PBS reimbursement of this medicine,\u201d said Marie Guillet, country president, AstraZeneca Australia and New Zealand.<\/p>\n<p>The Australian understands the company is highly likely to soon make a new application, which is why it has extended the drug\u2019s supply by six months. AstraZeneca has consistently said its decision is based on financial pressure from multiple fronts.<\/p>\n<p>\u201cZoladex monthly (3.6mg) has decades of clinical use in Australia and around the world,\u201d Dr Guillet said. \u201cIt is, however, expensive to manufacture and the accumulation of years of inflation has increased the manufacturing cost, despite productivity improvements. On the other hand, the price is less than half what it was when first listed in 1991.<\/p>\n<p>\u201cUniversal and equitable access to medicines is critical to the continued health of Australians. The PBS will require appropriate funding to ensure Australians are not denied access to medicines.\u201d <\/p>\n<p>The federal government last week announced it would <a class=\"body-link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/relief-for-breast-cancer-patients-as-zoladex-equivalent-drug-fasttracked\/news-story\/83259da5d4585db8f68f3c03dadb9565\" target=\"_blank\" data-tgev=\"event119\" data-tgev-container=\"bodylink\" data-tgev-order=\"83259da5d4585db8f68f3c03dadb9565\" data-tgev-label=\"health\" data-tgev-metric=\"ev\" rel=\"nofollow noopener\">make the drug Triptorelin, sold as Dishereline, available on the PBS<\/a> from October for a range of conditions including breast cancer, endometriosis and uterine fibrosis. The drug is considered an alternative to Zoladex.<\/p>\n<p>Health Minister Mark Butler said women should be able to access the medicines they need without barriers and that he would \u201c<a class=\"body-link\" href=\"https:\/\/www.theaustralian.com.au\/nation\/labors-health-policy-provides-cheaper-medicines-for-over-one-million-women\/news-story\/dd1bb3c0efba25f63bcd53ee67086fd1\" target=\"_blank\" data-tgev=\"event119\" data-tgev-container=\"bodylink\" data-tgev-order=\"dd1bb3c0efba25f63bcd53ee67086fd1\" data-tgev-label=\"nation\" data-tgev-metric=\"ev\" rel=\"nofollow noopener\">continue to make sure women have access to affordable treatment,<\/a> more choice and better care\u201d.<\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/australian-patients-risk-losing-lifesaving-medicines-amid-pharmaceutical-subsidy-crisis\/news-story\/9fb9250d21bdf486789e6eb8a9b23681\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"1\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australians risk losing access to world\u2019s best drugs, clinical trials\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Australians risk losing access to world\u2019s best drugs, clinical trials\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/50808576a91e5c8df186b7fc77b68006.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/australian-patients-risk-losing-lifesaving-medicines-amid-pharmaceutical-subsidy-crisis\/news-story\/9fb9250d21bdf486789e6eb8a9b23681\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"1\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Australians risk losing access to world\u2019s best drugs, clinical trials<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/australian-patients-risk-losing-lifesaving-medicines-amid-pharmaceutical-subsidy-crisis\/news-story\/9fb9250d21bdf486789e6eb8a9b23681\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"1\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australians risk losing access to world\u2019s best drugs, clinical trials\" rel=\"nofollow noopener\" target=\"_blank\">The nation faces being cut out of lifesaving treatments and cutting-edge research, say top doctors and pharmaceutical companies, who blame unrealistic prices and global disruption.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/mounjaro-rejection-explains-why-our-access-to-cheaper-medicines-if-failing\/news-story\/4dfa49eaed31169be19df03047b6a504\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"2\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Mounjaro\u2019s scathing rejection explains why drug access is failing\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Mounjaro\u2019s scathing rejection explains why drug access is failing\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/dff5a1bde21a8cdb575898ef7d80d864.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/mounjaro-rejection-explains-why-our-access-to-cheaper-medicines-if-failing\/news-story\/4dfa49eaed31169be19df03047b6a504\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"2\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Mounjaro\u2019s scathing rejection explains why drug access is failing<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/mounjaro-rejection-explains-why-our-access-to-cheaper-medicines-if-failing\/news-story\/4dfa49eaed31169be19df03047b6a504\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"2\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Mounjaro\u2019s scathing rejection explains why drug access is failing\" rel=\"nofollow noopener\" target=\"_blank\">Eli Lilly warns more medicines won\u2019t get subsidised in Australia as hundreds of thousands of patients are forced to pay full price for the diabetes treatment.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/theyre-on-the-pbs-but-xavier-still-cant-access-these-cancer-drugs\/news-story\/bebf8b74fdc07c10c0a3cc65f8450778\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"3\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Why Xavier needs to go to the US for his cancer drugs\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Why Xavier needs to go to the US for his cancer drugs\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/51528e157c359397f7068921c6f66957.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/theyre-on-the-pbs-but-xavier-still-cant-access-these-cancer-drugs\/news-story\/bebf8b74fdc07c10c0a3cc65f8450778\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"3\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Why Xavier needs to go to the US for his cancer drugs<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/theyre-on-the-pbs-but-xavier-still-cant-access-these-cancer-drugs\/news-story\/bebf8b74fdc07c10c0a3cc65f8450778\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"3\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Why Xavier needs to go to the US for his cancer drugs\" rel=\"nofollow noopener\" target=\"_blank\">The eight-year-old and his family will travel to America next month to pick up medicine that is subsidised in Australia \u2013 but not for him.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/australias-drug-approval-system-faces-reckoning-but-government-stalls-on-reforms\/news-story\/b958fc3a3e756b207342f4497a1ee087\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"4\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018An afterthought\u2019: Patients left waiting in drug price war\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"\u2018An afterthought\u2019: Patients left waiting in drug price war\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/62351961e5366172e03c9fedffef60b5.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/australias-drug-approval-system-faces-reckoning-but-government-stalls-on-reforms\/news-story\/b958fc3a3e756b207342f4497a1ee087\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"4\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">\u2018An afterthought\u2019: Patients left waiting in drug price war<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/australias-drug-approval-system-faces-reckoning-but-government-stalls-on-reforms\/news-story\/b958fc3a3e756b207342f4497a1ee087\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"4\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018An afterthought\u2019: Patients left waiting in drug price war\" rel=\"nofollow noopener\" target=\"_blank\">Health Minister Mark Butler has tied long-overdue drug pricing reforms to July negotiations with pharma, leaving Australia\u2019s medicines approval system under pressure<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/chronic-underfunding-created-a-dysfunctional-medicine-system-in-nz\/news-story\/62ee01d7db849c4475b5d295b735bf8c\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"5\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Patients \u2018who could be cured\u2019 are dying in NZ\u2019s drug-funding crisis\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Patients \u2018who could be cured\u2019 are dying in NZ\u2019s drug-funding crisis\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/3e9eb50e93e664305e4e2051bafc551d.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/chronic-underfunding-created-a-dysfunctional-medicine-system-in-nz\/news-story\/62ee01d7db849c4475b5d295b735bf8c\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"5\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Patients \u2018who could be cured\u2019 are dying in NZ\u2019s drug-funding crisis<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/chronic-underfunding-created-a-dysfunctional-medicine-system-in-nz\/news-story\/62ee01d7db849c4475b5d295b735bf8c\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"5\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Patients \u2018who could be cured\u2019 are dying in NZ\u2019s drug-funding crisis\" rel=\"nofollow noopener\" target=\"_blank\">New Zealanders have faced years of being locked out of access to new medicines. It\u2019s a warning for Australia, says a leading doctor.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/when-big-pharma-clashes-with-public-policy-people-such-as-aimee-pay-the-price\/news-story\/cf937f473be3e26446690fa9a234c5b3\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"6\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Early menopause\u2019: women risk drastic measures as cancer drug cut\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"\u2018Early menopause\u2019: women risk drastic measures as cancer drug cut\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/2f40c9c83db57d395a11db331c8f6c67.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/when-big-pharma-clashes-with-public-policy-people-such-as-aimee-pay-the-price\/news-story\/cf937f473be3e26446690fa9a234c5b3\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"6\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">\u2018Early menopause\u2019: women risk drastic measures as cancer drug cut<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/when-big-pharma-clashes-with-public-policy-people-such-as-aimee-pay-the-price\/news-story\/cf937f473be3e26446690fa9a234c5b3\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"6\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Early menopause\u2019: women risk drastic measures as cancer drug cut\" rel=\"nofollow noopener\" target=\"_blank\">Mother of two and cancer patient Aimee Glen says the decision by a pharmaceutical giant to remove a crucial drug from Australian shelves is devastating.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/radical-cancer-advances-are-here-but-australia-is-missing-out\/news-story\/98712692972d213524c41d063e388eba\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"7\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australia is not ready for the future of cancer care\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Australia is not ready for the future of cancer care\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/66505d2b5703477569df895819b5dba4.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/radical-cancer-advances-are-here-but-australia-is-missing-out\/news-story\/98712692972d213524c41d063e388eba\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"7\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Australia is not ready for the future of cancer care<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/radical-cancer-advances-are-here-but-australia-is-missing-out\/news-story\/98712692972d213524c41d063e388eba\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"7\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australia is not ready for the future of cancer care\" rel=\"nofollow noopener\" target=\"_blank\">Huge leaps in treatments, partly driven by AI, may not be available here if we let innovation slide, says a leader in the field.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/newgen-medicines-are-available-for-migraine-and-arthritis-but-only-if-you-fail-the-old-drugs\/news-story\/714700eb4281256eb01906a59483d471\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"8\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Rationing system\u2019 denies patients next-gen drugs\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"\u2018Rationing system\u2019 denies patients next-gen drugs\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/a65343fbe2fd9db8d1853624bb2bda52.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/newgen-medicines-are-available-for-migraine-and-arthritis-but-only-if-you-fail-the-old-drugs\/news-story\/714700eb4281256eb01906a59483d471\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"8\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">\u2018Rationing system\u2019 denies patients next-gen drugs<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/newgen-medicines-are-available-for-migraine-and-arthritis-but-only-if-you-fail-the-old-drugs\/news-story\/714700eb4281256eb01906a59483d471\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"8\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Rationing system\u2019 denies patients next-gen drugs\" rel=\"nofollow noopener\" target=\"_blank\">Australia has a proud history of negotiating hard to get cheaper drugs, but there are fears the bargaining could come with nasty side effects.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/lives-on-the-line-as-medicines-become-a-global-bargaining-chip\/news-story\/67a67121d21eee918e5acaf9a65b82aa\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"9\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australian lives on the line in global battle over drug pricing\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Australian lives on the line in global battle over drug pricing\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/21aeccb5eb140d14de72cb33382f1e86.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/lives-on-the-line-as-medicines-become-a-global-bargaining-chip\/news-story\/67a67121d21eee918e5acaf9a65b82aa\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"9\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Australian lives on the line in global battle over drug pricing<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/lives-on-the-line-as-medicines-become-a-global-bargaining-chip\/news-story\/67a67121d21eee918e5acaf9a65b82aa\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"9\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Australian lives on the line in global battle over drug pricing\" rel=\"nofollow noopener\" target=\"_blank\">Our Pharmaceutical Benefits Scheme was designed for a different era. Now it\u2019s coming under huge pressure as worldwide disruption in medicines threatens patient access \u2013 and lives.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/health-minister-our-pbs-is-a-worldleading-scheme-but-it-can-be-better\/news-story\/ee25abff0a4bfb7147b913633a44edc4\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"10\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Our PBS must evolve or risk being overwhelmed by costly new drugs\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Our PBS must evolve or risk being overwhelmed by costly new drugs\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/ee040b4501a85df6e5ae9293e2423782.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/health-minister-our-pbs-is-a-worldleading-scheme-but-it-can-be-better\/news-story\/ee25abff0a4bfb7147b913633a44edc4\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"10\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Our PBS must evolve or risk being overwhelmed by costly new drugs<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/health-minister-our-pbs-is-a-worldleading-scheme-but-it-can-be-better\/news-story\/ee25abff0a4bfb7147b913633a44edc4\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"10\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Our PBS must evolve or risk being overwhelmed by costly new drugs\" rel=\"nofollow noopener\" target=\"_blank\">Australia\u2019s affordable medicines scheme was designed for another era. Now we need to make it sustainable for a market that is undergoing global change.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-rsv-vaccines-among-drugs-on-slow-track-in-nz\/news-story\/9e2100e1561b99d3c7a5846e1fd44783\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"11\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"NZ\u2019s in a free fall on medicines. Can we avoid the same fate?\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"NZ\u2019s in a free fall on medicines. Can we avoid the same fate?\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/469ed029ba6a0ce93afeee042ca9fbe6.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-rsv-vaccines-among-drugs-on-slow-track-in-nz\/news-story\/9e2100e1561b99d3c7a5846e1fd44783\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"11\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">NZ\u2019s in a free fall on medicines. Can we avoid the same fate?<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-rsv-vaccines-among-drugs-on-slow-track-in-nz\/news-story\/9e2100e1561b99d3c7a5846e1fd44783\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"11\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"NZ\u2019s in a free fall on medicines. Can we avoid the same fate?\" rel=\"nofollow noopener\" target=\"_blank\">Approvals are so slow that some drugs, even for common conditions, are not given a tick for years after being available elsewhere. Australia must take note.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/patients-in-limbo-as-price-disputes-swamp-pbs-medicine-approvals\/news-story\/16a140413ec2abe4527896a8a33dc393\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"12\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Drug price disputes swamp medicine approvals committee\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Drug price disputes swamp medicine approvals committee\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/8d06a8d91a9a65c5db083d7a89fece48.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/patients-in-limbo-as-price-disputes-swamp-pbs-medicine-approvals\/news-story\/16a140413ec2abe4527896a8a33dc393\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"12\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Drug price disputes swamp medicine approvals committee<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/patients-in-limbo-as-price-disputes-swamp-pbs-medicine-approvals\/news-story\/16a140413ec2abe4527896a8a33dc393\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"12\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Drug price disputes swamp medicine approvals committee\" rel=\"nofollow noopener\" target=\"_blank\">The body that\u2019s supposed to approve new drugs for listing on the PBS is instead forced to deal with pharma companies refusing to accept Australia\u2019s prices.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/ms-drugs-to-stay-on-pbs-after-stoush-over-pricing\/news-story\/e030f753312ccb1f34fa1b6a7603ca32\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"13\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Multiple sclerosis drugs saved from PBS pricing axe\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Multiple sclerosis drugs saved from PBS pricing axe\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/345945bfadf54d90f3a59487fc2ba12f.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/ms-drugs-to-stay-on-pbs-after-stoush-over-pricing\/news-story\/e030f753312ccb1f34fa1b6a7603ca32\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"13\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Multiple sclerosis drugs saved from PBS pricing axe<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/ms-drugs-to-stay-on-pbs-after-stoush-over-pricing\/news-story\/e030f753312ccb1f34fa1b6a7603ca32\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"13\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Multiple sclerosis drugs saved from PBS pricing axe\" rel=\"nofollow noopener\" target=\"_blank\">The price paid for key MS treatments Ocrevus and Kesimpta sparked a stoush between drug companies and the government. Health Minister Mark Butler has now received crucial advice.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/crohns-patients-missing-out-on-lifechanging-ibd-treatments\/news-story\/ac714eb8967db07da20ed9105b3952a7\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"14\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Kelly thought she was dying as \u2018sinister\u2019 Crohn\u2019s disease flared\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Kelly thought she was dying as \u2018sinister\u2019 Crohn\u2019s disease flared\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/30dc110b213671262ea19f10087687e4.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/crohns-patients-missing-out-on-lifechanging-ibd-treatments\/news-story\/ac714eb8967db07da20ed9105b3952a7\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"14\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Kelly thought she was dying as \u2018sinister\u2019 Crohn\u2019s disease flared<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/crohns-patients-missing-out-on-lifechanging-ibd-treatments\/news-story\/ac714eb8967db07da20ed9105b3952a7\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"14\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Kelly thought she was dying as \u2018sinister\u2019 Crohn\u2019s disease flared\" rel=\"nofollow noopener\" target=\"_blank\">Australia, where inflammatory bowel disease is prevalent, is locked out of some of the best treatment advances.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/revealed-the-medicines-denied-to-australian-patients\/news-story\/2b2ac55a43dd560da454df354b656ed0\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"15\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"The medicines Australian patients are missing out on\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"The medicines Australian patients are missing out on\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/47692fc109c2839e22bc7686ca4d2766.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/revealed-the-medicines-denied-to-australian-patients\/news-story\/2b2ac55a43dd560da454df354b656ed0\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"15\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">The medicines Australian patients are missing out on<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/revealed-the-medicines-denied-to-australian-patients\/news-story\/2b2ac55a43dd560da454df354b656ed0\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"15\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"The medicines Australian patients are missing out on\" rel=\"nofollow noopener\" target=\"_blank\">Australia\u2019s Pharmaceutical Benefits Scheme is facing its biggest challenge \u2013 and a new report reveals the drugs we are already being denied.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/rare-diseases-miss-out-on-drugs-as-australias-safety-net-fails-report-finds\/news-story\/dda06e88b78dc0482f9cbc030b6eac2b\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"16\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Teacher pays $20k for cancer drug Australia won\u2019t fund\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Teacher pays $20k for cancer drug Australia won\u2019t fund\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/420e3974254fdeb8d5d12c7c01105fdf.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/rare-diseases-miss-out-on-drugs-as-australias-safety-net-fails-report-finds\/news-story\/dda06e88b78dc0482f9cbc030b6eac2b\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"16\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Teacher pays $20k for cancer drug Australia won\u2019t fund<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/rare-diseases-miss-out-on-drugs-as-australias-safety-net-fails-report-finds\/news-story\/dda06e88b78dc0482f9cbc030b6eac2b\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"16\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Teacher pays $20k for cancer drug Australia won\u2019t fund\" rel=\"nofollow noopener\" target=\"_blank\">Craig\u2019s rare disease means he must crowdfund to afford his medicine as the \u2018orphan drugs\u2019 program to help patients like him is failing, a new report finds.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovys-pbs-listing-would-have-been-landmark-now-its-in-doubt\/news-story\/04336b463693766a44cfd11813eb38fe\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"17\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Why you won\u2019t be getting Wegovy on the PBS any time soon\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Why you won\u2019t be getting Wegovy on the PBS any time soon\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/20ef1132783e2fbae850affa5e0b2b83.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovys-pbs-listing-would-have-been-landmark-now-its-in-doubt\/news-story\/04336b463693766a44cfd11813eb38fe\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"17\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Why you won\u2019t be getting Wegovy on the PBS any time soon<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovys-pbs-listing-would-have-been-landmark-now-its-in-doubt\/news-story\/04336b463693766a44cfd11813eb38fe\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"17\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Why you won\u2019t be getting Wegovy on the PBS any time soon\" rel=\"nofollow noopener\" target=\"_blank\">The GLP-1 drug was recommended for listing on the Pharmaceutical Benefits Scheme for certain patients over seven months ago. Now the landmark deal has stalled.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-mounjaro-and-ozempic-a-health-boon-for-all-but-the-sickest\/news-story\/02fb3a0f71624b03e6258a0344487b87\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"18\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Can hardly walk\u2019, yet this doctor\u2019s patients can\u2019t get weight-loss drugs\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"\u2018Can hardly walk\u2019, yet this doctor\u2019s patients can\u2019t get weight-loss drugs\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/759f4f0adaa3487665304b20ca70e25d.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-mounjaro-and-ozempic-a-health-boon-for-all-but-the-sickest\/news-story\/02fb3a0f71624b03e6258a0344487b87\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"18\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">\u2018Can hardly walk\u2019, yet this doctor\u2019s patients can\u2019t get weight-loss drugs<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/wegovy-mounjaro-and-ozempic-a-health-boon-for-all-but-the-sickest\/news-story\/02fb3a0f71624b03e6258a0344487b87\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"18\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"\u2018Can hardly walk\u2019, yet this doctor\u2019s patients can\u2019t get weight-loss drugs\" rel=\"nofollow noopener\" target=\"_blank\">The failure so far to list Wegovy on Australia\u2019s PBS has become a case study in inequity as those with severe obesity struggle to access treatment.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/butler-wants-weightloss-drugs-on-pbs-as-usage-soars\/news-story\/d823b93895257d463aeb071b03d42df8\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"19\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Butler says weight-loss meds must be listed on the PBS\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Butler says weight-loss meds must be listed on the PBS\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/e42d1f779107e1beb817ea5dc1786c97.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/butler-wants-weightloss-drugs-on-pbs-as-usage-soars\/news-story\/d823b93895257d463aeb071b03d42df8\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"19\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Butler says weight-loss meds must be listed on the PBS<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/butler-wants-weightloss-drugs-on-pbs-as-usage-soars\/news-story\/d823b93895257d463aeb071b03d42df8\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"19\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Butler says weight-loss meds must be listed on the PBS\" rel=\"nofollow noopener\" target=\"_blank\">Responding to stories featured in The Australian, the Health Minister says the new class of weight-loss drugs are too important not to be subsidised for those who need them.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/keytruda-tumouragnostic-pbs-access-to-benefit-10000-patients\/news-story\/850fd7585da4437319d8013bd426ab43\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"20\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Keytruda now affordable to thousands more cancer patients\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"Keytruda now affordable to thousands more cancer patients\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/17bb63837be57a3de5705dc3e49ee844.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/keytruda-tumouragnostic-pbs-access-to-benefit-10000-patients\/news-story\/850fd7585da4437319d8013bd426ab43\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"20\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">Keytruda now affordable to thousands more cancer patients<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/keytruda-tumouragnostic-pbs-access-to-benefit-10000-patients\/news-story\/850fd7585da4437319d8013bd426ab43\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"20\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"Keytruda now affordable to thousands more cancer patients\" rel=\"nofollow noopener\" target=\"_blank\">The multi-tumour listing of the key immunotherapy drug on the PBS ends a devastating inequity in public subsidisation, giving 10,000 patients lifesaving access for as little as $25.<\/a><\/p>\n<p><a class=\"storyblock_image_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/pancreatic-cancer-struck-abby-at-29-the-only-hope-was-a-world-away\/news-story\/583659390749f68ef44f88e8fb5d4427\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"21\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"In Abby\u2019s name: sister joins push for better access to medicines\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"responsive-img_img storyblock_img\" width=\"1280\" height=\"720\" alt=\"In Abby\u2019s name: sister joins push for better access to medicines\"  src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/09\/5144ea5ad4eff0305b202fa150a79467.jpeg\"  loading=\"lazy\"\/><\/a><a class=\"storyblock_title_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/pancreatic-cancer-struck-abby-at-29-the-only-hope-was-a-world-away\/news-story\/583659390749f68ef44f88e8fb5d4427\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"21\" data-tgev-label=\"story\" data-word-match=\"\" data-tgev-container=\"na\" rel=\"nofollow noopener\" target=\"_blank\">In Abby\u2019s name: sister joins push for better access to medicines<\/a><\/p>\n<p class=\"storyblock_standfirst g_font-body-s\"><a class=\"storyblock_standfirst_link\" href=\"https:\/\/www.theaustralian.com.au\/health\/medical\/pancreatic-cancer-struck-abby-at-29-the-only-hope-was-a-world-away\/news-story\/583659390749f68ef44f88e8fb5d4427\" data-tgev=\"event10\" data-tgev-metric=\"npv\" data-tgev-order=\"21\" data-tgev-label=\"story\" data-tgev-container=\"na\" aria-label=\"In Abby\u2019s name: sister joins push for better access to medicines\" rel=\"nofollow noopener\" target=\"_blank\">A 29-year-old mother was told Australia had nothing to offer in her fight against advanced pancreatic cancer. Her sister says the family\u2019s ordeal is far from unique.<\/a><\/p>\n<p>A separate three-monthly Zoladex implant, for men with prostate cancer, remains unaffected by any of the changes to supply. However, the drug has now been approved for use for the management of oestrogen receptor-positive early and advanced breast cancer in pre- and perimenopausal women.<\/p>\n<p>A decision is pending on whether the PBAC will recommend it for PBS listing for those conditions. With alternatives now available, AstraZeneca\u2019s community access program to the 3.6mg Zoladex implant will not proceed.<\/p>\n<p>Want to get healthy? Sign up to our free newsletter for trusted tips on diet, fitness, medical breakthroughs and guidance on sex and relationships <a class=\"body-link\" href=\"https:\/\/www.theaustralian.com.au\/newsletters\/health\" target=\"_blank\" data-tgev=\"event119\" data-tgev-container=\"bodylink\" data-tgev-order=\"health\" data-tgev-label=\"newsletters\" data-tgev-metric=\"ev\" rel=\"nofollow noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"AstraZeneca will delay the withdrawal of breast cancer drug Zoladex from the Australian market while it attempts to&hellip;\n","protected":false},"author":2,"featured_media":130014,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20662],"tags":[52273,52295,52225,52242,52260,52289,39974,52309,39936,52227,52228,52240,52305,52287,52318,52229,52256,35520,52276,52322,20638,52310,52275,52291,52248,11153,52324,583,11730,41792,52316,52284,52246,5935,52314,52282,52261,52252,16548,52270,22968,46686,5119,52264,52294,52233,52230,52312,52269,52266,52321,148,52253,21166,1259,52234,52278,52296,52283,52244,52255,49545,52277,52299,52236,52288,52226,2717,9845,52306,52320,52238,52279,52302,52267,52274,10469,10470,52263,39934,52285,52293,2718,52308,27265,52254,52292,52250,22856,6181,22970,2522,52243,52297,52249,52251,2713,52259,52265,41733,39950,22039,52247,52262,39898,52315,39914,52245,52281,52313,4405,52258,52298,52237,50408,52317,52272,52241,39906,52301,52319,39978,52290,39941,52323,52271,39714,52280,52268,52300,52239,52231,52257,52286,52304,52307,52224,52303,52311,3507,35127,27263,52232,52235],"class_list":["post-130013","post","type-post","status-publish","format-standard","has-post-thumbnail","category-astrazeneca","tag-s-community-access-program","tag-s-first-application","tag-s-removal","tag-s-supply","tag-52260","tag-2028-zoladex","tag-3-6mg","tag-a-community-access-scheme","tag-a-drug","tag-a-favourable-market","tag-a-major-contributor","tag-a-new-application","tag-a-new-price","tag-a-price-adjustment","tag-a-range","tag-a-relisting","tag-a-very-real-threat","tag-access","tag-affected-patients","tag-affordable-treatment","tag-alternatives","tag-an-alternative","tag-anger","tag-appropriate-funding","tag-april-30","tag-astrazeneca","tag-astrazeneca-australia","tag-australia","tag-australian","tag-australians","tag-barriers","tag-better-care","tag-both-sides-the-dispute","tag-breast-cancer","tag-breast-cancer-drug-zoladex","tag-carousela-separate-three-monthly-zoladex-implant","tag-clinical-use","tag-closed-door-negotiations","tag-conditions","tag-considerable-amendments-or-drug-makers","tag-country-president","tag-decades","tag-diet","tag-dishereline","tag-dr-guillet","tag-endometriosis-and","tag-endometriosis-or-hormone-receptor-positive-metastatic-breast-cancer","tag-extensive-and-sustained-efforts","tag-fierce-patient-backlash","tag-financial-pressure","tag-financial-reasons","tag-fitness","tag-growing-concern","tag-guidance","tag-inflation","tag-its-3-6mg-dose","tag-its-decision","tag-its-disappointment","tag-its-intention","tag-its-lower-dose-zoladex-implant","tag-just-weeks","tag-last-week","tag-less-than","tag-marie-guillet","tag-may-1","tag-may-2027","tag-medical-breakthroughs","tag-medicines","tag-men","tag-more-choice","tag-multiple-fronts","tag-new-pbs-push","tag-new-zealand-the-australian","tag-no-alternative-option","tag-no-avail","tag-no-guarantee","tag-november","tag-october","tag-oestrogen-receptor-positive-early-and-advanced-breast-cancer","tag-ongoing-access","tag-our-free-newsletter","tag-patient-groups","tag-patients","tag-patients-and-advocates","tag-pbs","tag-pbs-prescriptions","tag-pbs-removal","tag-pre-and-perimenopausal-women-a-decision","tag-productivity-improvements","tag-prostate-cancer","tag-purpose","tag-sales","tag-sex-and-relationships","tag-shelves","tag-similar-international-markets","tag-six-months","tag-supply","tag-the-3-6mg-zoladex-implant","tag-the-accumulation","tag-the-australian-market","tag-the-changes","tag-the-company","tag-the-continued-health","tag-the-continued-pbs-reimbursement","tag-the-decision","tag-the-disease","tag-the-drug","tag-the-drug-maker","tag-the-drug-triptorelin","tag-the-federal-government","tag-the-government","tag-the-management","tag-the-manufacturing-cost","tag-the-medicines","tag-the-move","tag-the-new-plan","tag-the-other-hand","tag-the-pbac","tag-the-pbs","tag-the-pbs-listing","tag-the-pharmaceutical-benefits-advisory-committee","tag-the-pharmaceutical-benefits-scheme","tag-the-pledge","tag-the-price","tag-the-time","tag-the-withdrawal","tag-the-world","tag-the-zoladex-3-6mg-monthly-implant","tag-their-decision","tag-their-lives","tag-their-ovaries-removed-the-withdrawal","tag-their-sex-hormones","tag-this-medicine","tag-this-seriesdisplay-style","tag-those-conditions","tag-trusted-tips","tag-universal-and-equitable-access","tag-uterine-fibrosis","tag-vital-cancer-drug","tag-women","tag-years","tag-zoladex","tag-zoladex-monthly","tag-zoladex-health-minister-mark-butler"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/130013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=130013"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/130013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/130014"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=130013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=130013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=130013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}